Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Butzkueven

Showing results (281-290 of 390) with videos related to

Pageof 39
Sort By:
Brain : a Journal of Neurology|November 30, 2022
Not all roads lead to the immune system: the genetic basis of multiple sclerosis severityVilija G Jokubaitis, Maria Pia Campagna, Omar Ibrahim, et al.
Annals of Neurology|December 30, 2014
Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosisTomas Kalincik, Dana Horakova, Tim Spelman, et al.
JAMA Neurology|August 8, 2018
Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple SclerosisJordana Hughes, Vilija Jokubaitis, Alessandra Lugaresi, et al.
Journal of the Neurological Sciences|October 11, 2025
Subjective neuropsychological deficits in autoimmune encephalitis: Patient-informant discrepancies and cognitive test outcomesKatherine Y Ko, Nabil Seery, Christina Kazzi, et al.
Journal of Neurology|April 14, 2025
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort studyPakeeran Siriratnam, Saif Huda, Anneke Van der Walt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 2021
Prediction of multiple sclerosis outcomes when switching to ocrelizumabMichael Zhong, Anneke van der Walt, Jim Stankovich, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 30, 2011
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase RegistryStella Hughes, Timothy Spelman, Maria Trojano, et al.
Neurology|November 19, 2024
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSDPakeeran Siriratnam, Saif Huda, Anneke Van Der Walt, et al.
Plos One|July 7, 2012
Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndromeClaire Meyniel, Timothy Spelman, Vilija G Jokubaitis, et al.
Journal of Neurology|September 29, 2025
Subjective psychiatric symptoms in post-acute autoimmune encephalitis: findings from the Australian autoimmune encephalitis consortiumKatherine Y Ko, Christina Kazzi, Nabil Seery, et al.
Pageof 39

Showing results (281-290 of 390) with videos related to

Sort By:
Pageof 39
Brain : a Journal of Neurology|November 30, 2022
Not all roads lead to the immune system: the genetic basis of multiple sclerosis severityVilija G Jokubaitis, Maria Pia Campagna, Omar Ibrahim, et al.
Annals of Neurology|December 30, 2014
Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosisTomas Kalincik, Dana Horakova, Tim Spelman, et al.
JAMA Neurology|August 8, 2018
Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple SclerosisJordana Hughes, Vilija Jokubaitis, Alessandra Lugaresi, et al.
Journal of the Neurological Sciences|October 11, 2025
Subjective neuropsychological deficits in autoimmune encephalitis: Patient-informant discrepancies and cognitive test outcomesKatherine Y Ko, Nabil Seery, Christina Kazzi, et al.
Journal of Neurology|April 14, 2025
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort studyPakeeran Siriratnam, Saif Huda, Anneke Van der Walt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 2021
Prediction of multiple sclerosis outcomes when switching to ocrelizumabMichael Zhong, Anneke van der Walt, Jim Stankovich, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 30, 2011
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase RegistryStella Hughes, Timothy Spelman, Maria Trojano, et al.
Neurology|November 19, 2024
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSDPakeeran Siriratnam, Saif Huda, Anneke Van Der Walt, et al.
Plos One|July 7, 2012
Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndromeClaire Meyniel, Timothy Spelman, Vilija G Jokubaitis, et al.
Journal of Neurology|September 29, 2025
Subjective psychiatric symptoms in post-acute autoimmune encephalitis: findings from the Australian autoimmune encephalitis consortiumKatherine Y Ko, Christina Kazzi, Nabil Seery, et al.
Pageof 39